Indocyanine Green Nanoparticles for Theranostic Applications

Citations Over TimeTop 10% of 2013 papers

Abstract

Abstract Theranostics is a concept that integrated imaging and therapy. As an emerging field, it embraces multiple techniques to arrive at an individualized treatment purpose. Indocyanine green (ICG) is a near infrared dye that has been approved by Food and Drug Administration (FDA) in USA for the use in indicator-dilution studies in humans. ICG nanoparticles (NPs) have attracted much attention for its potential applications in cancer theranostics. This review focuses on the preparation, application of ICG NPs for in vivo imaging (fluorescent imaging and photoacoustic imaging) and therapeutics (photothermal therapy, photodynamic therapy and photoacoustic therapy), and future directions based on recent developments in these areas. It is hoped that this review might provide new impetus to understand ICG NPs for cancer theranostics.

Related Papers

• → Emerging Designs of Activatable Photoacoustic Probes for Molecular Imaging(2016)169 cited
• → Indocyanine green fluorescence imaging in the surgical management of liver cancers: Current facts and future implications(2014)109 cited
• → Near-Infrared Fluorescence Imaging of Liver Metastases in Rats using Indocyanine Green(2011)43 cited
• → Progress of photoacoustic imaging combined with targeted photoacoustic contrast agents in tumor molecular imaging(2022)26 cited
• → Near-infrared fluorescence imaging with indocyanine green-lactosomes in a mouse model of rheumatoid arthritis(2016)5 cited